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PHARMACOLOGICAL STRESS TESTING in a myocardial scan is
an important option for patients unable to exercise, and
dipyridamole and adenosine triphosphate (ATP) have
been used in Japan. While adenosine has been widely used
in the US and Europe,1 it has become available in Japan
only recently in 2005,2–4 and the use of this vasodilator
drug will increase. The use of two intravenous lines for
adenosine and radiopharmaceuticals is generally recom-
mended, but injection through a single line, namely con-
tinuous adenosine injection with co-infusion of 201Tl or
99mTc perfusion imaging agents at 3 minutes, has also
been used for the sake of convenience. In the setting of the
single-route injection, intermission and displacement of
adenosine in the infusion line may cause significant fluc-
tuation in the concentration in the left ventricle (LV) or
coronary arteries. However, actual serial variation in
adenosine concentration in LV cannot be easily measured
in humans. Thus, the purpose of this study is to estimate
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Objective: Adenosine, which has been used for a myocardial perfusion scan, shows rapid clearance
from blood because of its short half-life of <10 seconds. This simulation study evaluates influences
of modes of radionuclide injection on ventricular adenosine concentration when one intravenous
injection line is used. Methods: Assuming that radionuclide injection is a unit impulse, time-activity
curves were measured in the left ventricle (LV) and fitted by a gamma function. Typical patterns
of concentration fluctuation when adenosine infusion was temporarily modified were calculated by
the convolution integral of input function and unit impulse response. Variation of concentration was
measured by experiments using continuous 99mTc injection and co-infusion of water via a three-way
stopcock. Modes of co-infusion with various infusion speeds and volumes were examined. Results:
Intermission of adenosine infusion and rapid displacement by radionuclide co-injection significantly
influenced the adenosine concentration in LV. Intermission of adenosine infusion for 2 seconds
caused a 15% decrease in the adenosine concentration in the left ventricle. When a square-shaped
input was assumed, a three-fold higher concentration of adenosine for 3 seconds created by
radionuclide injection resulted in a +42% increase in the LV concentration. Based on a measured
input function, radionuclide injection using three-way stopcock through one route caused a two- to
three-fold increase in the steady concentration in the vein just after injection. When 0.5 ml of
radionuclide was slowly co-injected, with three ways opened, it caused a relatively low fluctuation,
creating a  +34% to −47% change in concentration of LV. A flush of radionuclide with physiological
saline significantly increased the adenosine concentration in LV, when short half-lives were
assumed. Conclusion: An intravenous adenosine and radiopharmaceutical injection in the same
line is feasible. However, the fluctuation of concentration depends significantly on the mode of
injection. To minimize the fluctuation, a slow injection of a small volume of a myocardial imaging
agent via a co-injection route, with three ways opened, is recommended.
Key words:   adenosine, myocardial perfusion imaging, adverse effect, simulation
Annals of Nuclear Medicine486 Kenichi Nakajima, Junichi Taki, Tatsuya Yoneyama, et al
the fluctuation of concentration depending on the modes
of adenosine and radiopharmaceutical injection. More-
over, fundamental knowledge regarding the effect of
input and transfer function on the concentration in LV




When a radionuclide and drugs are injected into the
antecubital vein, they pass through the arm vein, right
ventricle, lungs, LV and coronary arteries to reach the
myocardium. The time-activity curves on a specific re-
gion show gradual widening and lower peaks during
transit. If temporal changes in concentration in the injec-
tion site are given, and transfer function from the arm to
LV is measured, the concentration in the LV can be
estimated mathematically. Namely, if input is defined as
a delta function, and unit impulse response h(t) is known
as a function of transfer, then the output will be calculated
by the convolution integral of input f(t) and h(t): f(t) (*)
h(t) [(*) indicates convolution integral].
In this experimental study, since we could not directly
measure the serial adenosine concentration, adenosine
concentration was substituted by radionuclide activity,
and injected radiopharmaceutical was substituted by
non-labeled water. Therefore, the condition in which
continuous adenosine infusion was modified by the co-
injection of radiotracer was simulated by that in which
continuous 99mTc pertechnetate infusion was modified by
the  co-injection of water. In this manuscript, experimen-
tal 99mTc and water correspond to adenosine and radio-
pharmaceuticals  (99mTc MIBI, tetrofosmin and 201Tl),
respectively. The connection of syringe, infusion lines,
three-way stopcocks and reservoir is shown in Figure 1.
To clearly present the model, the term “infusion” is used
for continuous injection of 99mTc pertechnetate, and the
term “co-injection” for water via a three-way stopcock.
Estimation of input function
To measure 99mTc input function from the infusion pump,
the changes in count a(t) (count/sec) were determined by
the product of concentration at time t in the infusion line
(B(t)) (count/ml) and injection flow F (ml/sec): a(t) = F *
B(t) [* indicates multiplication]. Although the concentra-
tion of 99mTc at time t can be measured by the region of
interest (ROI) 1 in Figure 1, the flow during manual
injection cannot be accurately determined. However, since
the accumulated reservoir count q can be measured, the
rate of change (count/sec) can be calculated by the first
derivative dq/dt. Therefore, we decided to measure the
count in ROI 2. When we co-injected water through a
three-way stopcock, both temporary intermission or re-
duction in 99mTc count and rapid displacement took place,
followed by return to a steady state.
Unit impulse response
A time-activity curve in the LV was measured using
radionuclide angiography performed for a cardiac study
in normal LV function. Although it was impossible to
achieve complete bolus injection as a delta function, a
small amount of radionuclide <0.5 ml was injected as a
good bolus, and the time-activity curve in the outflow of
LV was recorded. This curve was fitted by the gamma
function,
Fig. 1   Infusion of 99mTc and co-injection of water. The accumulation curve was measured on the
reservoir and the differentiation can generate the input function. The three-way stopcock was used as
two ways or three ways opened as indicated by the arrows.
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y = (t^a)*c*exp(−t/b) (1),
where a, b and c are coefficients of the gamma function,
and recirculation was excluded. Similarly, in a patient
with heart failure (output 1555 ml/min/m2, ejection frac-
tion 20%), the time-activity curve was obtained. These
two gamma function curves were used as typical unit
impulse response functions.
Definition of time-activity curves in LV
Although the time-activity curve of the LV was defined by
equation 1, adenosine was supposed to show decay during
transit. The right-hand side of equation 1 was then multi-
plied by 0.5^(TLV/T1/2) as a decay correction factor (DCF):
y = (t^a)*c*exp(−t/b)/A*DCF,
where TLV is an average arrival time to LV and assumed
to be 10 seconds for normal output and 15 seconds for
heart failure. T1/2 is an effective half-life of adenosine,
which is assumed to be 10 seconds. The term A is a
correction factor to make an integral of gamma function
from t = 0 to infinite 1.
Flushing by physiological saline
The effect of flushing radionuclide using physiological
saline (10 ml) displaced adenosine in the tube and veins,
and the arrival time to LV may have been shortened. In
this flushing model, although changes in concentration in
ROIs 1 and 2 flushed with saline could be measured, the
shortening of the arrival time to LV could not be meas-
ured. We thus assumed that flushing by physiological
saline shortened the arrival time by 5 seconds at maxi-
mum, and the degree of shortening was smaller as it
approached LV. Based on the small volume of ordinarily
injected myocardial imaging agent, we assumed that the
arrival time to LV was not altered without flushing.
Data analysis
All the data analysis mentioned above was obtained by
Mathematica Version 5.2 (Wolfram Research, Inc.). For
fitting the time activity curves, a gamma function was
used. For noise reduction in the time-activity curve,
weighted temporal smoothing was used. Differentiation
of the curve was performed by a 5-point formula of
the numerical differentiation method. The convolution
was performed by convolution of a kernel and list using
Σr Kr as−r. Since fluctuation of the activity shows one or
more negative or positive peaks, changes of fluctuation
were expressed from the steady condition. The duration of
significant fluctuation was defined as >+20% or –20%
from the steady condition. When multiple peaks were
observed, the time from the initial to the last fluctuation
was calculated.
Fundamental patterns of input function and time-activity
curve in LV
The effect of the input function on the LV curve was
calculated using a basic square-shaped input function.
Effects of intermission of continuous injection and dura-
tion of increase or decrease in concentration were ana-
lyzed.
Experiment 1: Rate of injection of myocardial imaging
tracers
To examine the rate of injection, the following four
modes were used. A syringe containing 300 MBq of 99mTc
in 25 ml was prepared and injected at the constant infusion
rate of 200 ml/h (0.055 ml/sec). (1) Two ml of water was
co-injected for 1 second from the three-way stopcock with
two ways opened. Namely, 99mTc infusion was tempo-
rarily stopped by the stopcock, when the water was co-
injected. Thereafter, the stopcock was returned to the
original position, and 99mTc flow returned to the constant
flow rate again. (2) Two ml of water was co-injected for
1 second from the three-way stopcock with three ways
opened. 99mTc infusion was continued during co-injec-
tion. (3) Two ml of water was co-injected slowly for 5
seconds, which was otherwise similar to the situations in
1 and 2. (4) Two ml of water was co-injected very slowly
for 10 seconds, which was otherwise similar to the situa-
tions in 1 and 2.
Experiment 2: Volume and mode of injection with three
ways opened
In the same setting as that of experiment 1, the volume
of water co-injection was changed to 0.5, 1, 2 and 3 ml
with three ways opened, and it was not flushed with saline.
In addition, 1 ml of a water was co-injected slowly for 5
seconds. No intermission of 99mTc infusion occurred
during water co-injection.
Experiment 3: Volume and mode of injection with two
ways opened
This experiment was performed to evaluate the change
in concentration when two ways of the three-way stop-
cock was opened. In ordinary injection through the three-
way stopcock, the continuous flow is transiently stopped
during co-injection of radiopharmaceuticals. After the
injection is finished, continuous injection is restarted. To
simulate this condition, we used a water volume of 0.5, 1,
2 and 3 ml with bolus injection, which was not flushed
with saline.
Experiment 4: Flushing with physiological saline
When adenosine injection was followed by flushing
with a large amount of physiological saline, it may have
reached the coronary artery with the higher concentration.
The change in concentration was measured after flushing
of 10 ml of water. Although the flushing would shorten the
arrival time to the LV, the effect of flushing could not be
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accurately estimated. Then we assumed that the arrival
time to LV was shortened by 5 seconds, and the effect of
shortening was linearly decreased within 10 seconds after
injection. The effective half-life of adenosine was as-
sumed to be 1, 2, 5 and 10 seconds.5,6
RESULTS
Fundamental patterns after injection
When a square-shaped input function was used, the time
activity curve reached a plateau in 30 seconds in the
normal patient and in 35 seconds in the heart-failure
patient after the time point of 1% of the injected activity
appeared in the LV (Fig. 2). When the arrival time from
the arm to the LV was assumed to be 10 to 20 seconds, the
activity became a constant 40 to 60 seconds after intrave-
nous injection. After the cessation of the intravenous
injection, the activity was zero 40 to 60 seconds later,
depending on the cardiac function.
Intermission of adenosine injection
Switching the passage of injection routes in the three-way
stopcock temporarily interrupted input of adenosine. As
shown in Table 1, intermission of 1, 2, 5 and 10 seconds
resulted in a decrease in concentration to 93%, 86%, 66%
and 46%, respectively. Duration of an intermission in 2
seconds did not generate a significant drop (<80%) in
concentration, but 5 and 10 second durations generated a
decreased concentration for 13 and 19 seconds in LV. In
the heart-failure condition, the degree of decrease was
less significant compared with that of the normal patient.
Fluctuation of adenosine concentration
Changes in concentration for 3 seconds from 0.2-fold to
3-fold resulted in changes of 83% to 142% in LV. A three-
fold concentration, as seen in rapid adenosine infusion,
for 1 to 9 seconds resulted in a 114% to 215% increase in
concentration in LV. The duration of fluctuation was 14 to
24 seconds. The degree of fluctuation was less in the heart-
failure patient.
Experiment 1: Injection speed
An injection of two ml of water was used in this
experiment. When the concentration curve was observed,
the concentration just after injection showed a 2 to 3-fold
Fig. 2   A square-shaped input function and the simulated
concentration curve in the LV by the convolution integral
processing. The lower panel indicates the gamma-functions
showing normal and heart failure conditions.
Table 1   Fundamental characteristics of simulated adenosine injection and concentration in the left ventricle
Normal output Heart failure
Simulated situation
Peak Duration of Peak Duration of
 fluctuation* fluctuation*
Intermission of infusion
intermission 1 sec 93% 0 95% 0
intermission 2 sec 86% 0 90% 0
intermission 5 sec 66% 13 76% 10
intermission 10 sec 46% 19 54% 23
Concentration and duration of changes
× 0.2, 3 sec 83% 0 88% 0
× 0.5, 3 sec 90% 0 93% 0
× 2.0, 3 sec 121% 4 115% 0
× 3.0, 3 sec 142% 14 129% 15
× 3.0, 1 sec 114% 0 110% 0
× 3.0, 3 sec 142% 14 129% 15
× 3.0, 5 sec 168% 19 148% 23
× 3.0, 7 sec 193% 21 166% 25
× 3.0, 9 sec 215% 24 184% 30
The steady concentration is defined as 100%. * defined as out of ±20% from the first to the last peak
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increase in the vein (Fig. 3). When two ways of three-way
stopcock were opened with 1 second of intermission and
2 ml of water co-injection, 99mTc activity decreased to
89%, then increased to 149%, and decreased again to
86%. In contrast, when water was co-injected with three
ways opened, 99mTc was flushed by the water and the
concentration was temporarily increased and then it de-
creased. In this condition, when water was injected rap-
idly (1 second), slowly (5 seconds) and very slowly (10
seconds), the first peak of increase was 115 to 145%, and
the second decreased peak was 49 to 69%. A very slow
injection prolonged the duration of fluctuation.
Experiment 2: Volume and modes of injection with three
ways opened
In this experiment, the water was co-injected as a bolus,
and the volume was changed (Table 2). This injection
temporarily increased the concentration in LV, caused by
the displacement of water, and then the concentration was
decreased (Fig. 3A). When the volume of 0.5 to 3 ml was
co-injected, the initial peak was 163 to 177% and the
second decrease was 63 to 91%. The duration of fluctuation
was shortened by 0.5 ml of water injection, but was 30
seconds for 1 to 3 ml of injection. In the heart-failure
condition, the peak of fluctuation was less but the duration
was 17 to 33 seconds. When 1 ml of water was slowly
injected for ~5 seconds, the initial peak was 134%, and the
Table 2   Simulated adenosine injection and concentration in the left ventricle in 4 experiments
Normal output Heart failure
Simulated situation First Second Third Duration of First Second Third Duration of
peak peak peak fluctuation* peak peak peak fluctuation*
Experiment 1
2-way, Intermission 1 sec, adenosine 2 ml/1 sec 89% 149% 86% 11 sec 95% 127% 94%   9 sec
3-way, No intermission, adenosine 2 ml/1 sec 115% 69% 11 sec 107% 79%   6 sec
3-way, No intermission, adenosine 2 ml/5 sec 145% 64% 24 sec 128% 79% 27 sec
3-way, No intermission, adenosine 2 ml/10 sec 134% 49% 32 sec 121% 65% 32 sec
Experiment 2: 3 ways opened
adenosine 0.5 ml, bolus 163% 91% 16 sec 143% 97% 18 sec
adenosine 1 ml, bolus 173% 76% 28 sec 148% 89% 17 sec
adenosine 2 ml, bolus 177% 67% 31 sec 150% 82% 17 sec
adenosine 3 ml, bolus 168% 63% 32 sec 143% 77% 33 sec
adenosine 1 ml, slow infusion 134% 53% 31 sec 123% 69% 29 sec
Experiment 3: 2 ways opened
adenosine 0.5 ml, bolus 97% 135% 80%   9 sec − 121% 91%   5 sec
adenosine 1 ml, bolus 99% 151% 82% 12 sec − 132% 92% 12 sec
adenosine 2 ml, bolus 97% 160% 92% 13 sec − 138% 98% 15 sec
adenosine 3 ml, bolus 70% 153% 91% 25 sec − 129% 98% 11 sec
Experiment 4: flushed with 10 ml of water, 3 ways opened
half life of adenosine 10 sec 127% 78% 24 sec 117% 84%   0 sec
half life of adenosine 5 sec 157% 82% 14 sec 138% 88% 15 sec
half life of adenosine 2 sec 327% 88% 25 sec 262% 90% 32 sec
half life of adenosine 1 sec 1354% 93% 34 sec 1001% 90% 46 sec
* defined as out of ±20% from the first to the last peak
Fig. 3   Typical input function and calculated concentration in
LV. A, injection with three ways opened; B, injection with two
ways opened; C, slow injection with three ways opened. The
peaks a, b and c indicate the first, second and third peaks. The
arrows indicate the delay of time-activity curves from the vein
to LV. Duration of fluctuation was defined as the interval, when
>20% or <−20% changes are observed (shaded areas).
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second negative peak was low (53%) with a whole
fluctuation time for 31 seconds.
Experiment 3: Volume and modes of injection with two
ways opened
With two ways opened, 99mTc co-injection temporarily
interrupted the flow by switching the stopcock. The input
function showed a small negative peak, then a positive
peak from an increased concentration, followed by a
small negative peak (Fig. 3B). The effect of fluctuation in
LV was less with <2 ml of water but was 70% with 3 ml
of water injection. The second peak showed a 135 to 160%
increase in LV. The total time of fluctuation was 9 to 25
seconds.
Experiment 4: Flushing with physiological saline
When 10 ml of physiological saline was used for
flushing 99mTc, the input function showed an initial in-
crease followed by a negative peak. The first peak in-
creased significantly with half-lives of 10, 5, 2 and 1
seconds assumed as shown in Table 2. If the adenosine
half-life was assumed to be 2 seconds, flushing of 99mTc
caused a rapid arrival to LV, which caused a high concen-
tration to 327% lasting for 25 seconds. If it was assumed
to be 1 second, the flushing caused a very high concentra-
tion to 1354% for 34 seconds.
DISCUSSION
The present study estimated fluctuation of adenosine
concentration in the heart when the modes of adenosine
infusion and co-injection of myocardial perfusion imag-
ing agents were modified. If the same injection route had
been used for constant adenosine infusion and 99mTc
radiopharmaceuticals co-injection, it would have resulted
in a 2 to 3-fold increased concentration in the vein just
after the injection site. When a three-way stopcock was
used with three ways opened during 99mTc radiopharma-
ceutical co-injection, the fluctuation of peak in the LV was
relatively low but lasted longer. This sort of fluctuation
was intuitively anticipated; however, the actual degree of
fluctuation was not evaluated, partly because the adeno-
sine concentration, whose half life is <10 seconds,5,6
could not be directly measured in LV.
Modes of adenosine injection and fluctuation in concen-
tration
The fundamental kinetic study showed that adenosine
concentration reached a plateau 1 minute after injection
and returned to a pre-injection condition after 1 minute.
Actual coronary dilatation in response to increased a-
denosine and cessation might have been delayed. In an
experimental study with dogs, coronary dilation reached
a peak 3 minutes after injection and returned to the pre-
injection condition 5 minutes later.7 Thus, the response of
dilatation seemed to be delayed for approximately 3
minutes. The data from the manufacturer showed that
duration required for coronary dilatation was <1 min in
half of the cases and <2 min for all cases with injection at
0.120 mg/min/kg. The disappearance of coronary dilata-
tion is <1 min in 1/3 and <2 min in 3/4 of the cases. In
contrast, some data showed that coronary dilatation was
observed even in a 15 second period. Thus, the time
required for coronary dilatation may depend on the doses
and experimental protocols. When a radiopharmaceutical
is injected in a usual manner, adenosine injection was
temporarily interrupted with a rotation of the three-way
stopcock. The time for interruption depends on the vol-
ume of injection, probably from 1 to several seconds,
resulting in a decrease in the adenosine concentration in
the vein and LV. To avoid the interruption, the radiophar-
maceutical can be injected with three-ways opened. In our
case, this caused a +60% to +80% increase in concentra-
tion which lasted for 20 to 30 seconds, followed by a
decrease for 20 to 30 seconds. A slow injection has been
useful to decrease the peak in fluctuation, although the
duration of fluctuation was still long. An injection of a
small volume was also important to reduce the degree of
fluctuation, preferably to less than 1 ml. The flushing of
radiopharmaceutical with 10 ml of physiological saline as
usually performed in radionuclide angiography shortened
the time to arrive at LV as a bolus, and the effect was
greater when the half-life of adenosine was assumed to be
shorter. Thus the flushing is inappropriate particularly
with assumption of a short half-life.
The speed of adenosine injection was recommended to
be 0.120 mg/min/kg. We usually took 0.24 ml/kg of
adenosine and diluted it with physiological saline to
obtain 20 ml of solution. Then the constant infusion rate
of 200 ml/hour (0.056 ml/sec) was used. In our clinical
situation, the three-way stopcock was placed in the near-
est position to the vein between the tube of the butterfly
needle and an extension tube. With this condition, the
volume of adenosine in a tube of the butterfly needle was
approximately 0.5 ml. When 0.5 ml of adenosine was
flushed with a radiopharmaceutical rapidly for 1 second,
the volume corresponding to 9 seconds (0.5/0.056) was
injected rapidly. Even if we had injected 0.5 ml of the
radiopharmaceutical for 9 seconds with three ways opened,
the adenosine concentration in the tube would have be-
come 1/2, and the passage would have been twice as fast.
Our experiment showed that the actual increase in the
injection site was 2 to 3-fold in concentration and not 9-
fold. In any case, we can understand that the fluctuation of
volume and time can significantly influence the concen-
tration in the vein and heart. Actual variation in coronary
flow is influenced by changes in venous return, respira-
tory movement, condition of vessels in the peripheral vein
and lung vasculatures, and other factors. Kajiya et al.
studied the stability of coronary flow and the variation was
±20% in 62% of cases with infusion rate of 0.12 mg/ml/
min.8 Our study also supported the findings that concen-
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tration was readily influenced by the hemodynamic
changes.
Adverse effects of adenosine
Adverse reactions were observed in approximately 81%
of 9256 consecutive patients, including minor and well-
tolerated side effects as well as chest pain caused by
ischemia.9 However, transient atrio-ventricular block
occurred in 706 patients and myocardial infarction in 1,
severe broncospasm in 7 and pulmonary edema in 1.
Although most of these reactions were generally well
tolerated and benign, caution should be observed during
adenosine injection to avoid serious effects. As to the
route of injection, injection through one infusion line was
associated with a slightly higher incidence of side effects,
compared with two intravenous lines for adenosine and
radiopharmaceuticals.10,11 When a single-port infusion
protocol was compared with the double-port infusion
protocol, the former had a higher incidence of chest pain
(57% vs. 44%), ST-segment depression (25% vs. 9%),
nausea (11% vs. 4%) and second- or third-degree atrio-
ventricular block (11% vs. 5%) in comparison to patients
in the latter group.11 Since both protocols showed similar
detectability for ischemia, they can be used in routine
diagnostic protocols.
Limitations
The present study evaluated fluctuations in LV but not
coronary dilatation directly. Therefore, the relationship
between coronary dilatation and concentration in LV and
the delay in response should be evaluated by new experi-
mental protocols, although continuous measurements of
the fluctuation of concentration in LV and actual coronary
flow are not easy, particularly in humans. In addition, the
relationship between the appearance of adverse effects
and adenosine concentration has not been determined and
probably depends on the individual patient. This study
evaluates input function, transfer of the radionuclide and
the possible fluctuations in the ventricles, and the kinetic
methodology may be applied to other radiopharmaceuti-
cal studies.
CONCLUSION
Intravenous injection through a single route is feasible,
but the changes in concentration are significantly influ-
enced by the modes of injection. The recommended
administration through one intravenous line is as follows:
The three-way stopcock should be placed in the nearest
position to the vein. The volume of injection should be
small, and the injection should be slow so as not to
displace the adenosine in the infusion line which can
reduce the fluctuation. The myocardial imaging agent
should be co-injected with three ways open, when a three-
way stopcock is used. Adenosine and myocardial imaging
agent should not be flushed with physiological saline.
Careful administration during adenosine injection, even
with a single injection line, could minimize the fluctuation.
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